Azienda Ospedaliera-Spedali Civili

Brescia 25123

0 studies enrolling now · 3 studies all time

What they study most

Adrenocortical Carcinoma, MDS, Myelodysplastic Syndrome, Paraganglioma, Pheochromocytoma, RAEB, Refractory Anemia With Excess Blasts, Renal Cell Carcinoma (RCC)

Studies at this site

• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma — Stopped early
• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early